Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI

Founder-led company

Maravai LifeSciences Holdings stock price today

$2.51
-2.99
-54.36%
Financial Health
0
1
2
3
4
5
6
7
8
9

Maravai LifeSciences Holdings stock price monthly change

-38.48%
month

Maravai LifeSciences Holdings stock price quarterly change

-38.48%
quarter

Maravai LifeSciences Holdings stock price yearly change

-17.42%
year

Maravai LifeSciences Holdings key metrics

Market Cap
741.84M
Enterprise value
1.75B
P/E
8.11
EV/Sales
1.99
EV/EBITDA
5.17
Price/Sales
2.04
Price/Book
3.30
PEG ratio
1.61
EPS
-0.98
Revenue
274.09M
EBITDA
-4.60M
Income
-131.04M
Revenue Q/Q
-18.78%
Revenue Y/Y
-61.81%
Profit margin
24.94%
Oper. margin
64.15%
Gross margin
80.87%
EBIT margin
64.15%
EBITDA margin
-1.68%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Maravai LifeSciences Holdings stock price history

Maravai LifeSciences Holdings stock forecast

Maravai LifeSciences Holdings financial statements

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Profit margin
Jun 2023 68.91M -6.54M -9.49%
Sep 2023 66.86M -6.46M -9.66%
Dec 2023 74.14M -105.95M -142.92%
Mar 2024 64.17M -12.07M -18.82%
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Analyst Estimates
Sep 2025 73.55M 896.56K 1.22%
Oct 2025 74.64M 1.35M 1.82%
Dec 2025 78.10M 2.55M 3.27%
Mar 2026 78.04M 810.01K 1.04%
  • Analysts Price target

  • Financials & Ratios estimates

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Debt to assets
Jun 2023 2264437000 1.36B 60.36%
Sep 2023 2267553000 1.37B 60.65%
Dec 2023 1487450000 697.56M 46.9%
Mar 2024 1444641000 667.25M 46.19%
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Cash Flow
Jun 2023 19.19M -24.15M -43.13M
Sep 2023 14.16M -15.52M 783K
Dec 2023 7.79M -12.90M 470K
Mar 2024 -8.46M -4.24M -560K

Maravai LifeSciences Holdings alternative data

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Employee count
Aug 2023 650
Sep 2023 660
Oct 2023 660
Nov 2023 660
Dec 2023 670
Jan 2024 670
Feb 2024 670
Apr 2024 650
May 2024 650
Jun 2024 570
Jul 2024 570

Maravai LifeSciences Holdings other data

31.25% -64.93%
of MRVI is owned by hedge funds
79.80M -46.82M
shares is hold by hedge funds

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI): Insider trades (number of shares)
Period Buy Sel
May 2024 0 9940974
Nov 2024 192500 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DEFORD JOHN A director Class A Common Stock 17,500 $5.75 $100,625
Purchase
HULL CARL director, officer.. Class A Common Stock 175,000 $5.64 $987,000
Sale
GTCR INVESTMENT XI LLC director, 10 percent owner:
Class A common stock 9,940,974 $9.82 $97,570,660
Purchase
HULL CARL Class A Common Stock 35,000 N/A N/A
Purchase
ORESHACK KURT
Class A Common Stock 7,500 $27 $202,500
Purchase
HOPFIELD JESSICA
Class A Common Stock 50,000 N/A N/A
Purchase
LUCIER GREGORY T
Class A Common Stock 15,000 $27 $405,000
Purchase
PRAHALAD MURALI
Class A Common Stock 18,000 N/A N/A
Purchase
HANCE ROBERT B
Class A Common Stock 10,000 N/A N/A
Purchase
SELLERS LISA
Class A Common Stock 18,888 $27 $509,976
Thursday, 5 December 2024
globenewswire.com
Tuesday, 12 November 2024
globenewswire.com
Saturday, 9 November 2024
seekingalpha.com
Tuesday, 15 October 2024
globenewswire.com
Thursday, 29 August 2024
zacks.com
Friday, 16 August 2024
reuters.com
Monday, 12 August 2024
globenewswire.com
Thursday, 8 August 2024
seekingalpha.com
Wednesday, 10 July 2024
globenewswire.com
Tuesday, 2 July 2024
globenewswire.com
Thursday, 20 June 2024
accesswire.com
Friday, 17 May 2024
zacks.com
Thursday, 9 May 2024
globenewswire.com
Wednesday, 8 May 2024
Seeking Alpha
Wednesday, 10 April 2024
GlobeNewsWire
Tuesday, 12 March 2024
GlobeNewsWire
Sunday, 11 February 2024
InvestorPlace
Monday, 29 January 2024
GlobeNewsWire
Thursday, 9 November 2023
GlobeNewsWire
Wednesday, 8 November 2023
Seeking Alpha
Tuesday, 17 October 2023
GlobeNewsWire
Tuesday, 8 August 2023
Seeking Alpha
Monday, 24 July 2023
GlobeNewsWire
Monday, 8 May 2023
Seeking Alpha
Zacks Investment Research
Monday, 17 April 2023
GlobeNewsWire
Monday, 13 March 2023
The Motley Fool
Wednesday, 8 March 2023
GlobeNewsWire
Wednesday, 22 February 2023
Seeking Alpha
Zacks Investment Research
  • What's the price of Maravai LifeSciences Holdings stock today?

    One share of Maravai LifeSciences Holdings stock can currently be purchased for approximately $2.51.

  • When is Maravai LifeSciences Holdings's next earnings date?

    Unfortunately, Maravai LifeSciences Holdings's (MRVI) next earnings date is currently unknown.

  • Does Maravai LifeSciences Holdings pay dividends?

    No, Maravai LifeSciences Holdings does not pay dividends.

  • How much money does Maravai LifeSciences Holdings make?

    Maravai LifeSciences Holdings has a market capitalization of 741.84M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 67.28% to 288.95M US dollars.

  • What is Maravai LifeSciences Holdings's stock symbol?

    Maravai LifeSciences Holdings, Inc. is traded on the NASDAQ under the ticker symbol "MRVI".

  • What is Maravai LifeSciences Holdings's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Maravai LifeSciences Holdings?

    Shares of Maravai LifeSciences Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Maravai LifeSciences Holdings's key executives?

    Maravai LifeSciences Holdings's management team includes the following people:

    • Mr. Carl W. Hull Co-Founder, Chairman & Chief Executive Officer(age: 66, pay: $1,250,000)
    • Mr. Brian Neel Chief Operating Officer of Nucleic Acid Production(age: 49, pay: $987,100)
  • Is Maravai LifeSciences Holdings founder-led company?

    Yes, Maravai LifeSciences Holdings is a company led by its founder Mr. Carl W. Hull.

  • How many employees does Maravai LifeSciences Holdings have?

    As Jul 2024, Maravai LifeSciences Holdings employs 570 workers, which is 12% less then previous quarter.

  • When Maravai LifeSciences Holdings went public?

    Maravai LifeSciences Holdings, Inc. is publicly traded company for more then 4 years since IPO on 20 Nov 2020.

  • What is Maravai LifeSciences Holdings's official website?

    The official website for Maravai LifeSciences Holdings is maravai.com.

  • Where are Maravai LifeSciences Holdings's headquarters?

    Maravai LifeSciences Holdings is headquartered at 10770 Wateridge Circle, San Diego, CA.

  • How can i contact Maravai LifeSciences Holdings?

    Maravai LifeSciences Holdings's mailing address is 10770 Wateridge Circle, San Diego, CA and company can be reached via phone at 858 546 0004.

Maravai LifeSciences Holdings company profile:

Maravai LifeSciences Holdings, Inc.

maravai.com
Exchange:

NASDAQ

Full time employees:

580

Industry:

Biotechnology

Sector:

Healthcare

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.

10770 Wateridge Circle
San Diego, CA 92121

CIK: 0001823239
ISIN: US56600D1072
CUSIP: 56600D107